BFS
RPRX icon

Bare Financial Services’s Royalty Pharma RPRX Stock Holding History

Bare Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04K Hold
72
– – ﹤0.01% 930
2026
Q1 		$3.45K Hold
72
– – ﹤0.01% 801
2025
Q4 		$2.78K Sell
72
-54
-43% -$2.06K ﹤0.01% 749
2025
Q3 		$4.45K Buy
+126
New +$4.56K ﹤0.01% 592

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bare Financial Services's RPRX Position: Q2 2026 in Review

Bare Financial Services held its Royalty Pharma (RPRX) position steady in Q2 2026 at 72 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Bare Financial Services first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.45K in Q3 2025. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Bare Financial Services held 72 shares of Royalty Pharma worth $4.04K as of Q2 2026.
  • Bare Financial Services left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #930 holding.
  • Bare Financial Services first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • Bare Financial Services's Royalty Pharma position peaked at $4.45K in Q3 2025.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.